TargetID: A novel strategy to find drug targets
The extensive data obtained will be useful beyond the end of this project
Source: timesofmalta.com
Stay updated with breaking news from Rd Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The extensive data obtained will be useful beyond the end of this project
Opus to advance preclinical development programs for BEST1- and RHO-related retinal diseases Opus Genetics, a patient-first, clinical-stage gene therapy company
From the blog of Justin Doebe at The Times of Israel
/PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization committed to finding treatments and cures for blinding retinal diseases, is...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!